Literature DB >> 16364518

The role of mesenchymal stem cells in haemopoiesis.

Francesco Dazzi1, Rajesh Ramasamy, Sarah Glennie, Simon P Jones, Irene Roberts.   

Abstract

The ontogeny of haemopoiesis during fetal life and the differentiation of blood cells in adult life depend upon a fully competent microenvironment to provide appropriate signals via production of soluble factors and cell contact interactions. The cellular constituents of the microenvironment, also defined as the haemopoietic niche, largely derive from a common progenitor of mesenchymal origin. Mesenchymal stem cells (MSC), initially identified in adult bone marrow, have also been described in fetal haemopoietic tissues where they accompany the migration of haemopoietic development. Their precise identity remains ill-defined because of the lack of specific markers. Their ability to self-renew and differentiate into tissues of mesodermal origin (osteocytes, adipocytes, chondrocytes) and their lack of expression of haemopoietic molecules are currently the main criteria for isolation. In the bone marrow the most important elements of the niche appear to be osteoblasts, whilst a less defined population of fibroblasts regulates the maturation of immature T cells in the thymus. Recently, MSC have been shown to exert a profound immunosuppressive effect on polyclonal as well as antigen-specific T cell responses by inducing a state of division arrest anergy. Thus, the multipotent capacity of MSC, their role in supporting haemopoiesis, and their immunoregulatory activity make MSC particularly attractive for therapeutic exploitation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364518     DOI: 10.1016/j.blre.2005.11.002

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  116 in total

1.  Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease.

Authors:  M Youd; C Blickarz; L Woodworth; T Touzjian; A Edling; J Tedstone; M Ruzek; R Tubo; J Kaplan; T Lodie
Journal:  Clin Exp Immunol       Date:  2010-04-29       Impact factor: 4.330

2.  MR spectroscopy and micro-CT in evaluation of osteoporosis model in rabbits: comparison with histopathology.

Authors:  Guan-wu Li; Guang-yu Tang; Yong Liu; Rong-biao Tang; Yi-feng Peng; Wei Li
Journal:  Eur Radiol       Date:  2011-11-22       Impact factor: 5.315

3.  Subcutaneous adipocytes may become osteoblasts.

Authors:  Simone Ciuffi; Sergio Fabbri; Roberto Zonefrati; Gianna Galli; Annalisa Tanini; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2012-05-29

Review 4.  Mesenchymal stem cells: Mechanisms of immunomodulation and homing.

Authors:  Hiroshi Yagi; Alejandro Soto-Gutierrez; Biju Parekkadan; Yuko Kitagawa; Ronald G Tompkins; Naoya Kobayashi; Martin L Yarmush
Journal:  Cell Transplant       Date:  2010-06-03       Impact factor: 4.064

5.  Basic fibroblast growth factor modulates cell cycle of human umbilical cord-derived mesenchymal stem cells.

Authors:  R Ramasamy; C K Tong; W K Yip; S Vellasamy; B C Tan; H F Seow
Journal:  Cell Prolif       Date:  2012-02-06       Impact factor: 6.831

Review 6.  Mesenchymal stem cells: the fibroblasts' new clothes?

Authors:  Muzlifah A Haniffa; Matthew P Collin; Christopher D Buckley; Francesco Dazzi
Journal:  Haematologica       Date:  2008-12-23       Impact factor: 9.941

Review 7.  Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine.

Authors:  Patricia Flores-Guzmán; Verónica Fernández-Sánchez; Hector Mayani
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

8.  Osteoblasts protect AML cells from SDF-1-induced apoptosis.

Authors:  Kimberly N Kremer; Amel Dudakovic; Meghan E McGee-Lawrence; Rachael L Philips; Allan D Hess; B Douglas Smith; Andre J van Wijnen; Judith E Karp; Scott H Kaufmann; Jennifer J Westendorf; Karen E Hedin
Journal:  J Cell Biochem       Date:  2014-06       Impact factor: 4.429

Review 9.  Mesenchymal stem cells in pathogenesis of myelodysplastic syndromes.

Authors:  Jingya Wang; Zhijian Xiao
Journal:  Stem Cell Investig       Date:  2014-08-21

Review 10.  Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches.

Authors:  Marina Konopleva; Yoko Tabe; Zhihong Zeng; Michael Andreeff
Journal:  Drug Resist Updat       Date:  2009-07-25       Impact factor: 18.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.